Decreased expression of interleukin 13 in human lung emphysema

被引:26
作者
Boutten, A
Bonay, M
Laribe, S
Leseche, G
Castier, Y
Leçon-Malas, V
Fournier, M
Durand, G
Aubier, M
Dehoux, M
Crestani, B
机构
[1] Hop Bichat Claude Bernard, INSERM, U408, F-75877 Paris 18, France
[2] Hop Bichat Claude Bernard, Serv Pneumol, F-75877 Paris, France
[3] Hop Bichat Claude Bernard, Serv Physiol Explorat Fonct, F-75877 Paris 18, France
[4] Hop Bichat Claude Bernard, Serv Biochim A, F-75877 Paris 18, France
[5] Hop Beaujon, Assistance Publ Hop Paris, Serv Pneumol, Paris, France
[6] Hop Beaujon, Assistance Publ Hop Paris, Serv Chirurg Thorac, Paris, France
关键词
D O I
10.1136/thx.2004.025247
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The overexpression of interferon (IFN) gamma or interleukin (IL)-13 in the adult murine lung induces the development of changes that mirror human lung emphysema. Methods: IL-13 and IFNgamma expression was determined in lung samples from five groups of patients: severe emphysema without alpha(1)-antitrypsin deficiency (SE+, n = 10); severe emphysema with alpha(1)-antitrypsin deficiency (SE2, n = 5); mild localised emphysema ( ME, n = 8); non-emphysema smokers ( NE-S, n = 9), and non-emphysema non-smokers ( NE-NS, n = 11). Lung IL-13 and IFNgamma mRNA were analysed by RTPCR. Lung concentrations of IL-13 protein were assessed by ELISA. Results: The expression of IFNgamma mRNA was similar in patients with or without emphysema. IL-13 mRNA was markedly decreased in the SE+ group compared with the SE2 ( p = 0.04), ME ( p = 0.02), and nonemphysema groups ( p = 0.01). IL-13 mRNA correlated with forced expiratory volume in 1 second ( r = 0.5, p = 0.04) and arterial oxygen tension ( r = 0.45, p = 0.03) in emphysema patients. In contrast to the nonemphysematous lung, IL-13 protein was below the detection limit of the assay in most emphysematous lung homogenates. Conclusion: The lung IL-13 content is reduced in patients with severe emphysema without alpha(1)-antitrypsin deficiency.
引用
收藏
页码:850 / 854
页数:5
相关论文
共 31 条
[1]   Medical progress: Chronic obstructive pulmonary disease. [J].
Barnes, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :269-280
[2]   α1-Antitrypsin deficiency•2:: Genetic aspects of α1-antitrypsin deficiency:: phenotypes and genetic modifiers of emphysema risk [J].
DeMeo, DL ;
Silverman, EK .
THORAX, 2004, 59 (03) :259-264
[3]   Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers [J].
Diaz, PT ;
King, MA ;
Pacht, ER ;
Wewers, MD ;
Gadek, JE ;
Nagaraja, HN ;
Drake, J ;
Clanton, TL .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (05) :369-372
[4]   Long-term risk of emphysema in patients with farmer's lung and matched control farmers [J].
Erkinjuntti-Pekkanen, R ;
Rytkonen, H ;
Kokkarinen, JI ;
Tukiainen, HO ;
Partanen, K ;
Terho, EO .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :662-665
[5]  
FINKE J, 1993, BIOTECHNIQUES, V14, P448
[6]   ALVEOLAR INFLAMMATION AND ITS RELATION TO EMPHYSEMA IN SMOKERS [J].
FINKELSTEIN, R ;
FRASER, RS ;
GHEZZO, H ;
COSIO, MG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1666-1672
[7]   Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension [J].
Fujita, M ;
Shannon, JM ;
Irvin, CG ;
Fagan, KA ;
Cool, C ;
Augustin, A ;
Mason, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (01) :L39-L49
[8]   Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung [J].
Hancock, A ;
Armstrong, L ;
Gama, R ;
Millar, A .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (01) :60-65
[9]   Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers [J].
He, JQ ;
Connett, JE ;
Anthonisen, NR ;
Sandford, AJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 28 (03) :379-385
[10]   Chronic obstructive pulmonary disease • 2:: Pathology and biochemistry of emphysema [J].
Hogg, JC ;
Senior, RM .
THORAX, 2002, 57 (09) :830-834